SRY effects on MAOA and RET expression could affect normal synaptogenesis and neurotransmission, and enteric nervous system development, and contribute to pathogeneses of diseases associated with these two genes, i.e. depression/cognitive disorders and Hirschsprung disease respectively. This evidence concerns the gene RET and depressive symptom measurement.